Indication
Pediatric Asthma
1 clinical trial
1 product
Clinical trial
Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen BankingStatus: Recruiting, Estimated PCD: 2025-06-30
Product
Azithromycin